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Immunological control of infections or tumors
depends on the release of effector cytokines and
polarized secretion of cytotoxic granules from
T cells and natural killer cells. Here we show that
the sorting receptor Sortilin controlled both pro-
cesses. In murine Sortilin-deficient cytotoxic T
lymphocytes, regulated secretion of granzyme A
and cytotoxic killing was enhanced and correlated
with increased vesicle-associated membrane pro-
tein 7 availability. In contrast, loss of Sortilin reduced
the release of interferon-g upon infections and in
autoimmune colitis. Exit of interferon-g from the
Golgi apparatus required the presence of Sortilin.
Furthermore, we tracked the transport route of inter-
feron-g beyond this Sortilin-dependent Golgi to early
endosome step. In wild-type T cells, trafficking of
interferon-g from the endosomal sorting platform to
the plasma membrane proceeded independently of
recycling endosomes, and interferon-g remained
excluded from late endosomes. Our results suggest
that Sortilin modulates systemic immune responses
through exocytic sorting of immunological effector
molecules.
INTRODUCTION
Elimination of virus-infected and tumorigenic cells requires
proper cytolytic activity by cytotoxic T lymphocytes (CTL), aided
by the cytotoxic response of natural killer (NK) cells and the
cytokine response of T helper type 1 (Th1) cells (Russell and
Ley, 2002). Cytolytic activity of T cells is determined by their
avidity for the major histocompatibility complex (MHC)-peptide
ligand, synthesis and storage of effector molecules, intracellular854 Immunity 37, 854–866, November 16, 2012 ª2012 Elsevier Inc.vesicle transport, and maturation of cellular organelles. CTL
selectivity requires specific recognition of MHC class I-peptide
complexes by the T cell receptor (TCR), which allows the precise
delivery of the cytolytic agents perforin and granzymes into the
immunological synapse (IS) via the regulated secretory pathway
(Fooksman et al., 2010). This process involves storage in and
release from lytic granules, also referred to as secretory lyso-
somes (Stinchcombe et al., 2004; Voskoboinik et al., 2006). In
contrast, secretion of the effector cytokines interferon-g (IFN-
g) and tumor necrosis factor-a (TNF-a) is dependent on the
constitutive secretory pathway, where newly synthesized
proteins pass through the Golgi apparatus and, upon TCR
engagement, are released at the plasma membrane in a pro-
tracted manner (Catalfamo et al., 2004; Fortier et al., 1989;
Huse et al., 2006). Genetically modified mouse strains or
T cells derived from patients with hereditary diseases have
provided insight into key mechanisms responsible for the trans-
port and release of granzymes from lytic granules (Stinchcombe
et al., 2004). However, there are no in vivo models for the molec-
ular dissection of IFN-g and TNF-a trafficking pathways from
CTLs, Th1 cells, and NK cells.
Here, we examined the cellular machinery that facilitates
transport of granzymes and IFN-g from the trans-Golgi net-
work (TGN) toward their endosomal-lysosomal destination. For
cathepsins and granzymes, delivery beyond the TGN to lyso-
somes is thought to depend on association with cation-depen-
dent and -independent mannose-6-phosphate receptors (CD-
M6PR and CI-M6PR) (Ghosh et al., 2003). This complex recruits
clathrin adaptors, followed by the formation of clathrin-coated
vesicles (CCVs) or carriers that transport the hydrolase-M6PR
complex to endosomes. The cargo-receptor complex dissoci-
ates in endosomes, the receptor recycles to the TGN, and the
hydrolase is targeted to secretory lysosomes. Trafficking steps
that regulate IFN-g anterograde transport to post-Golgi com-
partments remain to be resolved.
The vacuolar protein sorting 10 protein (Vps10p) receptor Sor-
tilin exhibits structural and functional similarity to the CI-M6PR
(Willnow et al., 2008). Both are type I transmembrane receptors
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accounts for the binding of cargo proteins. They also have
homologous signal sequences in their cytoplasmic domains
that interact with adaptor protein complexes and reside in the
same CCVs, which are transported from the TGN to endosomes
(Canuel et al., 2008; Mari et al., 2008; Robinson and Bonifacino,
2001).
Here, we provide evidence that Sortilin exhibits a dual role in
murine CTLs, NK cells, and Th1 cells. Although the regulated
release of granzyme A was enhanced as a result of an alteration
of the late endosomal trafficking regulator vesicle-associated
membrane protein 7 (VAMP7), loss of Sortilin abrogated the
constitutive delivery of IFN-g from the TGN to early endosomes.
Systemically, lack of IFN-g transport resulted in a compromised
immune response toward infectious stimuli and a dampened
autoimmune response in inflammatory bowel disease.
RESULTS
Sortilin Expression and Localization
To address the subcellular localization of Sortilin in cells of the
adaptive immune system, murine CD8+ T cells were transfected
with a Sortilin-GFP fusion protein. The major proportion of Sorti-
lin-GFP localized together with the Golgi marker GM130 and
the early endosome marker EEA1 (Figures 1A–1C). In contrast,
quantification of colocalization of Sortilin-GFP with the plasma
membrane marker CD8 or the lysosomal protease cathepsin D
showed only marginal overlap.
In wild-type (WT) mice, Sortilin gene expression was observed
in naive (day 0) and activated (day 3, 5) CTLs (Figure 1D). Corre-
spondingly, protein expression was detectable in lysates from
naive and activated CTLs (Figure 1E). Sort1/ mice exhibited
normal peripheral blood cell counts and Sort1+/+ and Sort1/
micedisplayedcomparable numbers and frequencies of lympho-
cyte subsets (B220+, CD4+, CD8+ and CD4+CD25+ regulatory
T cells) (data not shown).
Improved Allogeneic Cytotoxicity in Sort1–/– CTLs and
NK Cells
To investigate the role of Sortilin in the secretory pathway, we
generated CTLs from Sort1+/+ and Sort1/ splenocytes. The
number and activation status (CD8+CD25+, >95%) of CTLs
were comparable between Sort1+/+ and Sort1/ animals.
Applying enzymatic activity assays, we found that induced
secretion of the secretory lysosome marker granzyme A from
Sort1/ CTLs was considerably increased compared with WT
CTLs (Figure 2A, left). Release of the conventional lysosomal
enzyme b-hexosaminidase was unaffected (Figure 2A, right).
Detection of granzyme B in CTL supernatants elicited no mea-
surable difference betweenWT andSort1/CTLs (Figure 2B). In
immunoblot analysis, granzyme B exhibited indistinguishable
quantities, whereas granzyme A was reduced in Sort1/ CTLs
compared with WT CTLs (Figure 2C). Rapid loss of granzyme
A in Sort1/ CTLs could be reversed through inclusion of
brefeldin A (BFA) or in the presence of the lysosomal acidification
inhibitor concanamycin A (Figure 2D). Enhanced release of
functionally active granzyme A in Sort1/ mice translated into
increased allogeneic cytotoxicity in vitro (Figure 2E). The en-
hanced killing capacity of Sort1/ CTLs depended on theIrelease of granzyme-containing lytic granules, as shown by the
fact that WT and Sort1/ CTLs showed comparable strong
reductions in target cell lysis in the presence of concanamycin
A (Figure S1A available online). In the presence of the selective
granzyme A inhibitor FUT-175 (Poe et al., 1991), allogeneic cyto-
toxicity of Sort1/ CTLs was diminished (Figure S1B). Con-
versely, the magnitude of this reduction corresponded to the
gain of cytolytic capacity in Sort1/ CTLs (Figure 2E).
NK cells use a similar exocytosis apparatus for the regulated
release of cytolytic agents (Stinchcombe et al., 2004). Sort1/
NK cells exhibited enhanced release of granzyme A and im-
proved cytotoxic activity against YAC-1 target cells (Figures 2F
and 2G). Taken together, Sortilin deletion improves the in vitro
cytotoxicity of CTLs and NK cells, as mediated by enhanced
granzyme A activity.
Increased VAMP7 Expression in Sort1–/– CTLs
We analyzed the polarization of the lytic granule marker cathep-
sin D and the Golgi marker GM130 to the site of contact between
CTLs and CD3 CD28 antibody-coated microbeads (Figure S2A).
Upon encountering microbeads, granule reorientation in con-
jugated T cells occurred. In such cells, polarized cathepsin D
surrounded by GM130 staining toward the T cell-bead interface
was observed. Similar frequencies of conjugates demonstrated
tight polarization of lytic granules toward the IS (Figure S2B).
Thus, Sortilin does not affect IS formation.
In immunoblot analysis of Sort1+/+ and Sort1/ CD8+ total
lysates, comparable protein amounts were observed for several
soluble-N-ethylmaleimide-sensitive-factor accessory-protein re-
ceptors (SNAREs), SNARE-associated molecules, and sorting
receptors involved in endosomal-lysosomal trafficking (Fig-
ure 3A). The only exception was the vesicle (v)-SNARE molecule
VAMP7, which was upregulated about 2-fold in Sort1/ CTLs
(Figure 3B). A colocalization of Sortilin and VAMP7 could not
be visualized (Figure S2C). Treatment with lysosomal protease
inhibitors and cycloheximide increased VAMP7 protein expres-
sion in WT CTLs but not in Sort1/ CTLs (Figure 3C). We con-
clude that Sortilin could be involved in the trafficking and
recycling of VAMP7 to or from a degradative compartment.
VAMP7 interacts with the d subunit of adaptor protein com-
plex-3 (AP-3), and AP-3-depleted cells aberrantly sort CD63 to
the plasma membrane (Clark et al., 2003; Dell’Angelica et al.,
1999). We confirmed that CD63 cell surface localization was
decreased in VAMP7-overexpressing Sort1/ CTLs compared
with WT CTLs (Figure 3D). Furthermore, through siRNA-medi-
ated donwregulation of VAMP7, the release of granzyme A but
not b-hexosaminidase from CTLs was consistently decreased
(Figures 3E and 3F). Applying subcellular fractionation and
immunoblot analysis, no gross alteration in VAMP7 distribu-
tion or any other organelle markers was obtained (Figure S2D).
Trafficking of newly synthesized granzyme B in Sort1+/+ and
Sort1/ CTLs was indiscriminable, as shown by the fact that
in a pulse-chase experiment occurrence of the endoglycosi-
dase-H (EndoH)-resistant form, indicative of a proper transit
from the ER to the medial Golgi, was seen in both genotypes
after 20 min (Figure S2E).
To resolve the kinetics of granzyme redistribution, we incu-
bated Sort1+/+ and Sort1/CTLs at 19.5C to accumulate gran-
zymes in the Golgi and then shifted the temperature to 37Cmmunity 37, 854–866, November 16, 2012 ª2012 Elsevier Inc. 855
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Figure 1. Localization of Sortilin in T Cells
(A) CTLs from C57BL/6 WT mice (n = 5–6) were stimulated with anti-CD3 and CD28, followed by CD8+ purification, and transfected with GFP-tagged full-length
Sortilin (day 4). Cells were grown on coverslips and stained with anti-GM130, EEA1, cathepsin D, and CD8; blue, DAPI stain. Analysis was done by confocal
microscopy; images show medial confocal optical sections. Scale bars represent 5 mm.
(B) Quantitative analysis of Sortilin-GFP structures overlapping with the indicated organelle-specific markers. Bars show the Mander‘s coefficient indicating
a colocalization between Sortilin-GFP and the organellemarker. Data represent the mean ± SEM. Two independent experiments with at least 10–30 cells for each
marker protein were evaluated.
(C) Representative planes of a z series of confocal optical sections are shown for the markers with the highest colocalization coefficients. Images were taken at an
increment of 0.6 mm. Insets are 2- to 3-fold magnification of the overlap area. Scale bars represent 5 mm.
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Figure 2. Sortilin Deficiency Leads to an
Enhanced Release of Granzyme A and
Increased Allogeneic Cytotoxicity
(A and B) CTLs from BALB/c (WT, +/+) and
Sort1/ (/) mice were generated through anti-
CD3 CD28 stimulation and used at days 5–6.
Secretion of effector molecules was induced with
anti-CD3 CD28. After 4 hr, cell supernatant was
analyzed for granzyme A and b-hexosaminidase
activity (A). Granzyme B (B) content was analyzed
by ELISA. Bars show the mean ± SEM of seven (A)
and four (B) independent experiments. In each
experiment, pooled cells from three mice per
group were used.
(C) Equal amounts of Sort1+/+ and Sort1/
(C57BL/6) CTL lysates were analyzed by immu-
noblotting for granzyme A and B expression;
calnexin served as loading control. Antigen ex-
pression was quantified by densitometric scan-
ning. Granzyme expression was first calculated
relative to calnexin content and then these ratios
were compared between WT and Sort1/ CTLs
and expressed in percent. Bars show the mean ±
SD of seven independent experiments; CTLs were
pooled from at least two to three mice per group in
each experiment.
(A–C) p values were determined by Mann-Whitney
test; n.s., nonsignificant.
(D) Sort1/ CTLs were treated with or without
cycloheximide (CHX, 40 mg/ml), brefeldin A (BFA,
5 mg/ml), or concanamycin A (Con A, 0.5 mM) for
4 hr. Lysates were analyzed by immunoblotting
with anti-granzyme A and anti-calnexin. One
representative experiment of three experiments
performed with two animals per genotype in each
experiment.
(E) Cytolytic activity of MLR-derived CTLs (BALB/c, H-2d) against allogeneic MCA205 target cells (H-2b). One representative example of five independent
experiments is shown with pooled effector cells from three mice per group. Data represent mean values ± SEM of experiments performed in triplicate. On the
right, statistical presentation of cytolytic killing at the effector to target ratio 30:1. p values were determined by one-tailed Mann-Whitney test.
(F) NK cells (day 9) were generated from WT (C57BL/6) and Sort1/ mice. Release of granzyme A from NK cells was effectuated with PMA and ionomycin.
Bars show the mean of two independent experiments; NK cells were pooled from three mice per group in each experiment.
(G) Cytolytic activity of purified NK cells (C57BL/6, H-2b) against allogeneic YAC-1 target cells (H-2d). One representative example of two experiments is shown
with pooled effector cells from three mice per group. Data represent mean values of experiments performed in triplicate.
See also Figure S1.
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Sortilin Controls Sorting of Effector Moleculesto resume their anterograde transport (Figures 3G and 3H). At
0 min, a strong colocalization of granzyme A and granzyme B
in a perinuclear Golgi-like region indicated that both granzymes
accumulated in the Golgi because of low temperature arrest.
After 10 and 45 min, a clear vesicular staining pattern revealed
that both granzymes had passed the Golgi. In WT CTLs, gran-
zyme A exhibited considerable colocalization with granzyme
B-positive carriers, suggesting that both granzymes were trans-
ported via the same route. In contrast, granzyme A localization in
Sort1/ CTLs clearly deviated from this pattern, indicating that
Sortilin affected the intracellular redistribution toward a post-
Golgi compartment. Additionally, we excluded the possibility
that endocytic uptake and recycling of transferrin were influ-
enced by Sortilin (data not shown). In summary, decreased(D) Quantitative RT-PCR analysis of SortilinmRNA expression relative to GAPDH in
and CD28 stimulation (day 3 and 5). Results are representative of two independe
(E) Purified CTLs were used unstimulated (day 0) or stimulated (day 3 and 5). C
a loading control. One representative example of at least three experiments is sh
IVAMP7 lysosomal degradation in Sortilin/ CTLs was associ-
ated with decreased CD63 surface expression and enhanced
granzyme A release.
Strong Reduction of IFN-g Secretion in Sort1–/– Mice
Secretion of the effector cytokines IFN-g and TNF-a is putatively
dependent on the constitutive secretory pathway. Upon TCR ac-
tivation, IFN-g secretion was drastically diminished in Sort1/
compared to Sort1+/+ CTLs (Figure 4A). In keeping with the
data fromCTLs, Th1 (>2-fold) and NK (2-fold) cells from Sort1/
mice also exhibited greatly reduced IFN-g secretion (Figures 4B
and 4C). In contrast, in CTLs and Th1 cells derived from Sort1+/+
and Sort1/ mice, we could not detect a difference for TNF-a
(Figures S3A and S3B).murine naive CD8+ T cells (day 0) and activatedCTLs derived from an anti-CD3
nt experiments, with pooled CTLs from four mice for each group.
ell lysates were analyzed by immunoblotting for Sortilin; b-actin was used as
own.
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Figure 3. Sortilin Deficiency Results in a Compensatory Increase of VAMP7 Expression
(A) Equal amounts of Sort1+/+ (C57BL/6) and Sort1/ CTL lysates, generated from anti-CD3 CD28-stimulated T cells, were analyzed by immunoblotting for the
proteins indicated. SynaptotagminVII occurred in several splice variants. One representative example of at least three experiments is shown.
(B) Antigen expression was quantified by densitometric scanning. VAMP7 expression was first calculated relative to calnexin content and then these ratios were
compared between WT and Sort1/ CTLs and expressed in percent. Bars show the expression of VAMP7 ± SD of nine experiments.
(C) CTLs fromWTorSort1/micewere cultured on day 6 for 12 hr in the presence or absence (+/) of cycloheximide (CHX, 40 mg/ml) and the lysosomal protease
(PI) inhibitors E-64 (10 mg/ml) and leupeptin (1 mg/ml). Medium with inhibitors was exchanged after 6 hr. Protein lysates were analyzed by immunoblotting with
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CD3-precoated plates to distinguish constitutive and inducible
release (Ru¨der et al., 2009). Constitutive and induced discharge
of labeled proteins showed no difference between WT and
Sort1/ CTLs (Figure S3C). We conclude that Sortilin affects
the intracellular transit time of only a discrete set of secretory
proteins.
To study the immunological consequences of Sortilin deletion,
mice were challenged with adenoviruses at sublethal dosages.
On day 6 after infection, the serum concentration of IFN-g was
reduced by one-half in Sort1/ mice compared with WT mice
(Figure 4D). Reduction of serum IFN-g was not due to lower
T cell activation status in Sort1/ animals, as shown by the
fact that IL-2 serum concentration was similar compared with
WT controls (Figure S3D). Likewise, frequencies of CD4+IFN-g+
andCD8+IFN-g+ effector T cells from infectedmicewere compa-
rable in both genotypes (Figure 4E). Clearance of adenovirus-in-
fected hepatocytes requires IFN-g activity. Corresponding to
decreased circulating IFN-g serum concentrations, at day 6 after
adenovirus infection the activities of hepatic transaminases
alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) in Sort1/ mice were considerably higher (Figure 4F). In
accordance, when Sort1+/+ and Sort1/ mice were challenged
with L. monocytogenes at sublethal dosages, substantially en-
hanced concentrations of IFN-g in WT serum were measured
on day 2 and 6 (Figures 4G and 4H). Circulating serum IL-2
was similar in Sort1+/+ and Sort1/ mice (Figure S3E), likewise
peptide-specific restimulation of splenocytes demonstrated in-
distinguishable frequencies of CD8+IFN-g+ effector T cells in
both genotypes at days 6 (Figure 4I) and 8 (data not shown).
Uninfected Sort1+/+ and Sort1/ mice harbored comparable
amounts of serum IFN-g (Figures S3F and S3G). Gene-deleted
animals were compromised in their T cell-mediated clearance
function, as shown by the fact that L. monocytogenes-infected
Sort1/ mice exhibited substantially higher bacterial titers (day
5) in spleen comparedwithWTmice (Figure 4J). In an in vivo killing
assay against listeriolysin O (LLO)-peptide loaded splenocytes,
Sort1+/+ and Sort1/ mice infected with L. monocytogenes ex-
hibited a comparable cytolytic activity (Figure S4H).
The priming capacity of bone marrow-derived dendritic
cells (DCs) was compared with ovalbumin (OVA)-specific CD8+
T cells fromOT-I andCD4+ T cells fromOT-IImice as responders.
OVA-pulsed DC stimulators from Sort1+/+ and Sort1/ animalsanti-VAMP7. Representative examples out of three experiments performed are sh
densitometric scanning and expressed as in (B); the ratios were compared betw
(D) CTLs were stimulated for 4 hr with anti-CD3 CD28. Viable CD8-positive cells
representative example is shown. Bars show the mean values ± SEM for the geo
and Sort1/ CTLs; n = 8 for WT and n = 9 independent measurements for Sort1
(B–D) p value was determined by Mann-Whitney test.
(E) Sort1+/+ CTLs were transfected with siRNA specific for VAMP7 or a scrambled
analyzed by immunoblotting. One representative example out of seven experime
(F) Each data point represents data of one independent experiment. Secretion of e
was analyzed for granzyme A and b-hexosaminidase activity. p values were dete
(G) CTLs were transfected with granzyme A-Myc-Flag. CTLs were first incubated
indicated in Figure 1A. Images are presented as medial confocal optical secti
coefficient was performed on 6–10 optical sections for at least 10 cells. These
information. Scale bars represent 5 mm.
(H) Quantitative and time-resolved intracellular redistribution of granzyme A and B
Mander’s coefficient for each optical section of a z stack. Data are means ± SEM
In all panels, pooled CTLs from at least two to three mice per group in each exp
Iexhibited comparable stimulatory capacity for CD8+ and CD4+
T cells (data not shown).
Whereas the adenovirus infection model was evaluated at day
6, when CTLs experienced a peak in granzyme A gene expres-
sion (Figure S3I), serum from L. monocytogenes-infected mice
was also obtained on day 2 after infection. Thus, differences at
day 2 are probably attributable to IFN-g release from effector
cells other than conventionally primed ab T cells, such as gd
T cells, NK T cells, or possibly NK cells instead (Andersson
et al., 1998; Stetson et al., 2003). Peak IFN-g gene expression
was obtained at day 3 (Figure S3J). In summary, decreased
release of IFN-g in Sort1/ mice was not due to different
effector cell numbers, activation status, or synthesis rate.
Attenuation of Inflammatory Bowel Disease in Rag2–/–
Mice Transplanted with Sort1–/– CD4+CD25lo/– T Cells
Immunodeficient Rag2/mice were adoptively transferred with
sortedCD4+CD25lo/ T cells fromWT andSort1/mice (Figures
S4A and S4B). Transfer of regulatory T cell-deficient CD4+ T cell
populations into Rag2/ mice induces inflammatory bowel
disease (IBD), a condition in which IFN-g plays a leading role
(Ito and Fathman, 1997; Schneider et al., 2007). Rag2/ mice
that received WT T cells demonstrated an accelerated loss of
body weight (20%) within the 3 week observation period (Fig-
ure 5A). In the same time interval, Rag2/ mice reconstituted
with Sort1/ T cells lost only 5% of their initial body weight.
Circulating serum IFN-g was only 40% in Sort1/ T cell recipi-
ents compared to WT (Figure 5B). Histologic scoring of de-
scending colonic tissue specimens showed an altered frequency
distribution of severe colitis pathology (Figure S4C). Corre-
sponding with higher serum IFN-g concentrations, disease
scores >2 were more frequent in Sort1+/+ CD4+ T cell Rag2/
recipients (Figure 5C). CD3+ T cell infiltrates within mucosa and
submucosa in both groups were clearly detectable (Figure S4C).
We conclude that lack of Sortilin can partially protect from severe
tissue damage resulting from reduced IFN-g release.
In the Absence of Sortilin, IFN-g Is Retained in the Golgi
Complex
To investigate where the transport of IFN-g in CTLs and Th1 cells
in the absence of Sortilin might be compromised, we examined
IFN-g localization in CTLs. IFN-g and GM130 colocalization in
both genotypes under resting conditions revealed considerableown. VAMP7 and calnexin expression of all three experimentswas quantified by
een the different treatment groups.
were gated for analysis of CD63 fluorescence intensity by flow cytometry. One
mean fluorescence intensity (MFI) of CD63 cell surface expression on Sort1+/+
/.
siRNA as a negative control. After 24 hr, VAMP7 and calnexin expression was
nts performed is shown.
ffector molecules was induced with anti-CD3 CD28. After 4 hr, cell supernatant
rmined by Wilcoxon signed rank test; n.s., nonsignificant.
at 19.5C and then shifted to 37C for 10 and 45min. Cells were then stained as
ons. For each time point and genotype, statistical analysis of the Mander‘s
contiguous optical planes contained all the three-dimensional fluorescence
. Bars show the degree of colocalization of granzyme A and B, as determined by
of two independent experiments. p value was determined by Student’s t test.
eriment were used. See also Figure S2.
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Figure 4. Reduced Secretion of IFN-g in
Sortilin-Deficient Mice
(A) CTLs fromSort1+/+ (BALB/c) andSort1/mice
were generated through anti-CD3 CD28 stimula-
tion and used at days 5–6. Secretion of IFN-g was
induced with anti-CD3 CD28.
(B) In vitro differentiated Th1 cells were induced to
release IFN-g as in (A).
(C) NK cells (day 9) were generated from WT
(C57BL/6) and Sort1/ mice. Release of IFN-g
from NK cells was effectuated with PMA and ion-
omycin. After 4 hr, secretion was determined by
ELISA.
Bars show themean ± SD of nine (A, B) and two (C)
independent experiments; CTLs, Th1, and NK
cells were pooled from at least two to three mice
per group in each experiment.
(D) Sort1+/+ (C57BL/6) and Sort1/ mice were
challenged by injection (i.v.) of 1 3 108 PFU
adenovirus. On day 5 after challenge, IFN-g in vivo
capture antibody was injected (i.p.). After 20 hr,
secretion of IFN-g in the serum was analyzed by
in vivo capture assay. Three independent experi-
ments with 15 mice for each group were per-
formed.
(E) Splenocytes from adenovirus-infected mice
were restimulated overnight with adenovirus-
transduced WT DCs. For the final 4 hr of stimula-
tion, BFA was included. Splenocytes were stained
with anti-CD4 or CD8, followed by intracellular
anti-IFN-g detection and flow cytometry analysis.
Bars indicate the mean percentage of IFN-g+ cells
among the CD8+ or CD4+ T cells, ±SD of three
independent experiments with n = 10 mice for
each genotype and n = 3 naive mice.
(F) Bars indicate mean values ± SD and show the
enzymatic activity of the transaminases ALT and
AST in serum. Shown are data of two independent
experiments performedwith at least n = 7mice per
group.
(G) Sort1+/+ (BALB/c) and Sort1/ mice were in-
fected with 5 3 103 L. monocytogenes (i.v.).
(G and H) After 2 (G) and 6 (H) days, mice were
sacrificed and serum levels of IFN-gwere analyzed
by ELISA. Shown are data of two independent
experiments analyzed at day 2 (left) and day 6
(right).
(I) Bars indicate mean values ± SD and show the
frequencies of IFN-g+ cells among the CD8+
splenocytes 6 days after infection with L. monocytogenes and an additional restimulation for 4 hr with LLO-peptide or with PMA and ionomycin. Nrs, splenocytes
from infected mice, not restimulated. Shown are data of one experiment with n = 5 (WT), 7 (Sort1/), and 3 (naive) mice analyzed. n.s., nonsignificant.
(J) Sort1+/+ (BALB/c) and Sort1/mice were infected with 53 103 L. monocytogenes (i.v.). On day 5, mice were sacrificed and bacterial titers in spleen (colony
forming units, cfu) were determined. Results represent the mean ± SD of n = 12 WT and n = 14 Sort/ mice per group.
All p values were determined by Mann-Whitney test; n.s., nonsignificant. See also Figure S3.
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Sortilin Controls Sorting of Effector Moleculesaccumulation of IFN-g at the Golgi complex in Sort1/ CTLs,
whereas inWT CTLs IFN-gwasmore dispersed in a cytoplasmic
granular pattern (Figure 6A; Movies S1 and S2). Quantitation of
the ratios between IFN-g fluorescence in the Golgi versus whole
cell-localized fluorescence indicated that values for CTLs and
Th1 cells were increased, respectively, by 1.6-fold and 1.92-
fold in Sort1/ cells compared with Sort1+/+ cells (Figures 6B,
S5A, and S5B).
To resolve the kinetics of IFN-g transport from the Golgi
complex to the plasma membrane, we performed a temperature
block and shift experiment. In WT CTLs, only minor colocaliza-860 Immunity 37, 854–866, November 16, 2012 ª2012 Elsevier Inc.tion of IFN-g and GM130 persisted after 5 min, indicating that
IFN-g had passed the Golgi (Figures 6C and 6D). Accordingly,
immunofluorescence intensity of IFN-g in the Golgi region versus
thewhole cell as ameasure for transport kinetics decreased over
time (Figure 6D). In contrast, in Sort1/CTLs high colocalization
values of IFN-g and GM130 were obtained after 5 min, and these
values persisted 30 min after the temperature shift. Specific
interaction between Sortilin and IFN-gwas confirmed with coim-
munoprecipitation experiments in transfected HEK293 cells (Fig-
ure 6E), as well as by confocal microscopy (Figures S5C and
S5D). Most of this activity showed additional strong overlap
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Figure 5. Loss of Sortilin Mitigates Chronic
Colitis in the CD4+CD25lo/– Transfer Model
(A) Sorted CD4+CD25lo/ T cells from WT
(C57BL/6) or Sort1/ mice were adoptively
transferred into Rag2/ mice. Graph represents
weight loss in percent, expressed as mean
values ± SEM of two independent experiments
with n = 9 mice per genotype.
(B) Secretion of IFN-g into serum was measured at
day 21, when animals were sacrificed.
(A and B) Bars show mean values; p values as
determined by Student’s t test.
(C) Frequency distribution of histological disease scores were calculated based on the examination of H&E stainings of descending colon specimen.
Histologies were graded from 0 (unaffected) to 5 (most severe colitis).
See also Figure S4.
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Sortilin Controls Sorting of Effector Moleculeswith GM130, indicating that Sortilin acts as a sorting receptor for
IFN-g at the TGN.
Intracellular Trafficking of IFN-g in CTLs
To track the trafficking route of IFN-g in WT CTLs beyond its
passage through the Golgi, kinetics of transferrin routing upon
endocytosis and recycling were examined. Extensive colocaliza-
tion between IFN-g, transferrin, and the early endosome marker
EEA1 was observed beginning at 10 min and was stronger at
20 min (Figures 7A and 7B). At 45 min, these structures were
clearly separated, indicating that IFN-g and transferrin employed
distinct routes before their release at the plasma membrane.
Previously, costaining of IFN-g with Rab19+ vesicles at the IS
in Th1 cells has been demonstrated (Huse et al., 2006), but
a function for this Rab19+ carrier population is unknown. We
also observed transient IFN-g colocalization with Rab19+ organ-
elles, with 20 min delay (Figures 7A and 7B). Rab19+ and IFN-g+
structures were separated at 45 min. Overlap between Rab19+
vesicles and the recycling endosome marker Rab11 was not
observed (data not shown). Colocalization of endogenous
IFN-g with Rab3d+ secretory granules did not occur (Figures
7A and 7B). We conclude that Sortilin controls the transport of
IFN-g from the Golgi toward the endosomes, where the cytokine
route intersects with endocytosed transferrin and Rab19+ vesi-
cles. However, presuming that transferrin after its transit through
early endosomes subsequently enters a recycling endosome
compartment, we excluded that IFN-g entered such vesicles
for release. Although colocalization with IS-proximal Golgi com-
plexes was obtained, IFN-g lacked colocalization with the lytic
granule markers cathepsin D or Rab27a (Figures 7C and 7D;
data shown for cathepsin D). In summary, we suggest that under
physiologic conditions, secretion of IFN-g occurs on an alter-
native exocytic route, distinct from recycling endosomes and
secretory lysosomes.
DISCUSSION
In this study we demonstrate that Sortilin plays a pivotal role in
the regulation of the adaptive immune response through control
of two separate trafficking pathways in effector T cells and NK
cells. Sortilin loss conferred CTLs and NK cells with an enhanced
capacity for granzyme A release and improved allogeneic cyto-
toxicity in vitro. We suggest that compensatory upregulation of
the SNARE molecule VAMP7 in Sort1/ CTLs could account
for this effect. VAMP7, in conjunction with the counterstruc-Iture-SNAREs syntaxin 7, syntaxin 8, and vti1b, is required for
both homotypic late endosome fusion and heterotypic fusion
with lysosomes (Antonin et al., 2000; Pryor et al., 2004). In agree-
ment with our observation on CTLs, a role for VAMP7 in target
cell killing has been obtained in human NK cells, where siRNA-
mediated downregulation inhibits cytolytic activity (Krzewski
et al., 2011; Marcet-Palacios et al., 2008). Increased amounts
of VAMP7 in the absence of Sortilin is probably caused by pro-
tection from proteolytic degradation, as shown by the effect of
lysosomal protease inhibitors. In accordance neuronal BDNF
amounts are also modulated by Sortilin-dependent lysosomal
degradation (Evans et al., 2011).
Increased VAMP7 amounts could enhance the efficacy of
vesicle fusion, thereby improving granzyme delivery at the late
endosome to secretory lysosome trafficking step. VAMP7 inter-
feres with an AP-3-dependent trafficking step from endosomes
toward the lysosomal compartment; inmice that lack a functional
AP-3 complex, CD63 is missorted toward the plasmamembrane
(Clark et al., 2003; Rous et al., 2002). Reduced plasma mem-
brane delivery of CD63 and enhanced granzyme A release
from lytic granules would be consistent with a regulatory role
of Sortilin in these processes. Although Sortilin is unlikely to
interact with the membrane-bound molecule VAMP7 directly,
we envisage that Sortilin mediates instead transport of lyso-
somal enzymes to the site of VAMP7 degradation.
Differential release of granzyme A and B in a Sortilin-depen-
dent manner could relate to their complex posttranslational
modifications (Russell and Ley, 2002; Trapani, 2001). The proap-
optotic effects of both granzymes in target cells are nonredun-
dant, and it remained puzzling how the differential timing of cell
death induction through either granzyme A or B is regulated.
Enhanced provision of an enzymatic active granzyme A form in
the supernatant of Sort1/ CTLs could be in agreement with
the existence of specialized lysosomal compartments, lyso-
somal maturation stages, or trafficking routes, respectively,
that deliver the cytolytic agents at different speed (Russell and
Ley, 2002). We note that in the absence of Sortilin, granzyme A
trafficking deviated from the granzyme B routing, and further-
more the molecule was lost rapidly from intracellular stores;
this process was sensitive to post-Golgi transport or lysosomal
proteolysis inhibition.
In the absence of Sortilin, IFN-g release was drastically dimin-
ished. CTLs, Th1 cells, and NK cells share the basic exocytosis
machinery necessary to secrete common immunologic modula-
tors (Ru¨der et al., 2009; Stinchcombe et al., 2004). Themmunity 37, 854–866, November 16, 2012 ª2012 Elsevier Inc. 861
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Figure 6. Exit of IFN-g from the Golgi Is Severely Delayed in Sort1–/– CTLs
(A) CTLs from Sort1+/+ (C57BL/6) and Sort1/ (day 5) mice were stained with the antibodies indicated, followed by confocal microscopy analysis. Insets are 2- to
3-fold magnification of the Golgi zone.
(B) Bars show the ratio of Golgi-associated versus total cell-associated IFN-g fluorescence, as defined by GM130 positivity. Data are means ± SEM of three
independent experiments with n = 21 cells (Sort1+/+) and 35 cells (Sort1/) evaluated.
(C) CTLs were first incubated at 19.5C, and then shifted to 37C for up to 30 min. Cells were treated and stained as indicated in (A). Insets are 2- to 3-fold
magnification of the Golgi zone.
(A and C) Dashed white lines indicate cell boundaries; medial confocal optical sections are shown. Scale bars represent 5 mm.
(D) Quantitative and time-resolved evaluation of IFN-g exit from the Golgi complex. Bars show the ratio of Golgi-associated versus total cell-associated IFN-g
fluorescence at the indicated time points. Data are means ± SEM of three independent experiments with at least ten cells for each time point per group.
(B and D) p values were determined by Mann-Whitney test; n.s., nonsignificant.
(A–D) Cells were derived from at least eight mice per genotype.
(E) HEK293A cells were transiently transfected with Sortilin-Myc and IFN-g-Flag-Myc, then lysed and subjected to immunoprecipitation with anti-Flag-M2.
Coimmunoprecipitated Sortilin-Myc was detected by immunoblotting with anti-Myc. IFN-g-Flag-Myc was detected with anti-Flag-M2. Input was 1/20 volume of
the reaction mixture. L-chain, antibody light chain. One representative experiment out of three performed.
See also Figure S5 and Movies S1 and S2.
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Figure 7. IFN-g Is Released Separately from
Recycling Endosomes
(A) CTLs from C57BL/6 WT mice (day 5–6) were
incubated with Alexa Fluor-488-labeled transferrin
for 30 min. The recycling phase was induced by
washing the cells, followed by competition with
excessive unlabeled transferrin. Cells were seeded
on coverslips, precoated with anti-CD3 CD28 for
15 min at 4C, followed by a chase at 37C for the
times indicated. Cells were stained with the indi-
cated antibodies and analyzed by confocal micros-
copy. Medial confocal optical sections are shown,
with one representative example of at least two
experiments performed per staining. Cells were
derived from at least six to eight mice per genotype.
Insets are 2- to 3-fold magnifications of the fusion
zone between transferrin and organelle markers.
Scale bars represent 5 mm.
(B) Quantitative analysis of IFN-g structures over-
lapping with endocytosed transferrin and the
indicated organelle-specific markers. Bars show
Mander’s coefficient at the indicated time points.
Data are means ± SD of at least two independent
experiments with n = 10 cells for each time point per
staining.
(C and D) CTLs from WT mice were mixed with CD3
CD28 T cell expander beads. Conjugates were then
plated on coverslips for 30 min at 37C, fixed, and
stained with the antibodies indicated. One repre-
sentative example of at least two experiments with
n = 10 cells per staining is shown. Dashedwhite lines
indicate cell boundaries, and beads are pseudocol-
ored in white (overlay). Scale bars represent 5 mm.
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Sortilin Controls Sorting of Effector Moleculesadenovirus infection model proved that loss of Sortilin reduces
the physiologic clearance capacity, as indicated by the elevation
of liver enzymes. Destruction of adenovirus-transduced hepato-
cytes is usually attributed to the cytolytic activity of CD8+ T cells
(Yang et al., 1994), but IFN-g also decreases adenoviral trans-
gene expression (Sung et al., 2001). Enhanced liver damage
inSort1/micewould be consistent with a leading role of defec-
tive IFN-g secretion. In line with this interpretation, clearance ofImmunity 37, 854–866,L. monocytogenes from spleen was also
impaired in Sort1/ mice. For the effector
phase after in vivo challenge, we have to
consider two effects in the opposing
direction: a putatively protective effect re-
sulting from enhanced granzyme A release
and an immune response dampening effect
through IFN-g reduction. Consistent with
our in vivo data, it has been demonstrated
that mice deficient for the IFN-g receptor
have an increased susceptibility for
L. monocytogenes and vaccinia virus infec-
tions (Huang et al., 1993). On the other
hand, granzyme A-deficient mice are
shown to efficiently control LCMV and
L. monocytogenes infections (Ebnet et al.,
1995). More recently, it was found that
granzyme-deficient mice harbor even
lower L. monocytogenes titers anddecrease splenic pathology upon bacterial infection (Carrero
et al., 2008). This observation is explained by a LLO-mediated
apoptosis of T cells, an effect where granzymes are involved.
Moreover, human cell lines loaded with granzyme A differ in their
sensitivity to cytolysis (Beresford et al., 1999). Thus, the discrep-
ancy between in vivo and in vitro killing capacity of Sort1/
CTLs, as compared with WT animals, could be caused by the
employment of different target cell lines as well. Alternatively,November 16, 2012 ª2012 Elsevier Inc. 863
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Sortilin Controls Sorting of Effector Moleculesthe granzyme A increment observed in vitro might be too low to
translate into an in vivo effect.
In accordance with the infection models, induction of IBD
resulted in a milder colitis pathology in recipients of Sort1/
CD4+ T cells. The proinflammatory cytokine TNF-a is concur-
rently involved in IBD pathogenesis (Kojouharoff et al., 1997;
Wirtz et al., 1999). However, TNF-a release was unaffected by
loss of Sortilin; this finding may account for the colon lesions
observed in Sort1/ T cell recipients. Furthermore, unlike the
complete penetrance of IFN-g genetic deletion and the associ-
ated lack of an IBD phenotype (Ito and Fathman, 1997), in
Sort1/ mice IFN-g release was strongly diminished but not
ablated. We suggest that Sortilin modulates the adaptive and
innate immune responses by regulating IFN-g secretion.
Mechanistically, loss of Sortilin impaired release of IFN-g-
loaded carriers from the TGN. Consistent with the distribution
of the sorting receptor in neurons (Vaegter et al., 2011; Willnow
et al., 2008), the majority resided in the Golgi apparatus and in
early endosomes. Thus, Sortilin would be in an ideal position
to select soluble cargo molecules such as IFN-g for inclusion
into CCVs. We infer from our dynamic imaging experiments
on IFN-g and transferrin trafficking that during their itinerary,
transferrin, Sortilin, and IFN-g can pass through the same early
endosomal structures, but might leave the endosomal sorting
platform through different exit sites (Mari et al., 2008). During
the post-early endosomal recycling phase, colocalization of
transferrin and IFN-g was lost, indicating that IFN-g does not
employ a recycling endosomal trafficking route for secretion.
In activated Th1 cells, IFN-g is released at the IS in a polarized
fashion, whereas for TNF-a a multidirectional release has been
suggested (Huse et al., 2006). We confirmed preferential orien-
tation of IFN-g around the IS. Transient costaining with Rab19+
and recycling transferrin structures was observed along the
post-Golgi trafficking route of IFN-g; in contrast, Rab3d ex-
hibited essentially no colocalization. Although there is a paucity
of information about a specific role for Rab19 in exocytosis,
Rab3d seems to control the size of secretory granules (Riedel
et al., 2002).
In human NK cells, cotrafficking andmultidirectional release of
IFN-g and TNF-a has been shown (Reefman et al., 2010). In con-
trast, in our study on murine CTLs and Th1 cells, Sortilin strongly
influenced secretion of IFN-g but not TNF-a, indicating that
both cytokines employ separate secretory pathways. Differ-
ences between our findings and previous reports on murine
Th1 cells and human NK cells include analysis of transfected
T cells versus endogenously expressed cytokines and trafficking
regulators.
Our data indicate that Sortilin provides a layer of selectivity for
cargo molecules at the TGN. Loss of Sortilin strongly influenced
secretion of IFN-g and affected the availability of active gran-
zymeA. At the TGN, Sortilin recruited IFN-g into carriers destined
for the early endosomal sorting platform, followed by IFN-g sort-
ing into a vesicle compartment that was distinct from recycling
endosomes, late endosomes, and secretory lysosomes. IFN-g
has a dominant role in the modulation of the adaptive immune
response after infections, tumor growth, and chronic inflamma-
tion (Kennedy and Celis, 2008). Thus, through IFN-g trafficking,
the sorting receptor gains a key role in maintaining systemic
immune competence.864 Immunity 37, 854–866, November 16, 2012 ª2012 Elsevier Inc.EXPERIMENTAL PROCEDURES
Adenovirus Infection
Mice were challenged by injection (i.v.) of 13 108 PFU of replication-deficient
E1- and E3-deleted type 5 adenovirus encoding b-galactosidase (Lac-Z) (Wil-
limsky and Blankenstein, 2000). On day 5 after challenge, 10 mg IFN-gmAb per
mouse were injected (i.p.). After 20 hr, concentration of IFN-g in the serumwas
analyzed with mouse IFN-g in vivo capture assay set (BD Bioscience). Serum
concentration of IL-2 was determined by ELISA (BD Bioscience). To analyze
frequencies of effector T cells, splenocytes from infected mice were restimu-
lated with adenovirus-infected DCs (moi 20–50) overnight. For the final 4 hr
BFA (10 mg/ml) was included. Splenocytes were stained for IFN-g, CD4, and
CD8, respectively, and then T cells were analyzed by flow cytometry. Liver
damage was measured by quantifying the activity of the serum transaminases
ALT and AST (LABOKLIN). Animal experiments were approved by the Berlin
State review board at the Landesamt fu¨r Gesundheit und Soziales.
Listeria monocytogenes Infection
Mice were infected with the L. monocytogenes strain EGD essentially as previ-
ously described (Kursar et al., 2005). In brief, 5 3 103 bacteria in a volume of
200 ml PBS were injected into a lateral tail vein. Animals were sacrificed, and
concentrations of IFN-g and IL-2 in serum and tissue lysates were analyzed
by ELISA or IFN-g in vivo capture assay set. Peptide-specific restimulation to
quantitate frequencies of antigen-specific T cells was performed essentially
as described (Kursar et al., 2005). In brief, 4 3 106 cells were cultured for 4 hr
in 1 ml complete RPMI including 5 mg/ml BFA, in the presence of 106 M of
the peptide LLO190-201 or in the presence of PMA and ionomycin. Cultured cells
were then stained as described in Supplemental Experimental Procedures. For
determination of bacterial burdens in spleen, mice were killed, tissues were
homogenized in PBS, serial dilutions of homogenates were plated on tryptic
soy broth plates, and colonies were counted after 48 hr of incubation at 30C.
Induction of Inflammatory Bowel Disease
Flow cytometry-sorted 5 3 105 CD4+CD25lo/ T cells were transferred intra-
peritoneally into Rag2/ recipients. T cells were obtained from either Sort1/
or C57BL/6 WT donors. In average, the purity of transferred CD4+CD25lo/
T cells was in the range of 95% viable cells. Experimental animal groups
were age and sex matched. Animals were monitored clinically for weight
loss, and final evaluation was performed when mice lost 20% of their original
body weight. Animals were euthanized, serum was generated, and colons
were assessed histologically. Hematoxylin & eosin (H&E)-stained sections
were scored blindly according to the criteria detailed in Supplemental Exper-
imental Procedures.
Immunofluorescence
Cells were grown for 20 hr on poly-L-lysine-coated coverslips (Sigma). Cells
were fixed with 20C acetone or 3.5% PFA for 10 min on ice and washed
with PBS. Subsequently, cells were permeabilized with 0.2% TX-100 in PBS
for 5 min and blocked with 5% BSA in PBS for 30 min at room temperature.
Next, cells were incubated with primary antibodies in 1% BSA in PBS for 1 hr
at room temperature, washed, and exposed to a secondary fluorochrom-
conjugated antibody for 45 min at room temperature. After washing, slides
were mounted in Mowiol.
IFN-g and Granzyme A Transport Assay
CTLs (day 5) were seeded on poly-L-lysine-coated coverslips for 2 hr at 19.5C
to accumulate IFN-g and granzyme A and B in the Golgi, in the presence of
20 mM HEPES. Temperature was shifted to 37C for up to 30 min (IFN-g)
and 45 min (granzyme A and B) in the presence of 40 mg/ml cycloheximide.
Cells were fixed with 20C acetone or ice-cold 3.5% PFA, permeabilized,
and stained with specific antibodies. The ratio of IFN-g fluorescence in the
Golgi versus total cellular fluorescence was calculated at the indicated time
points applying ImageJ software 1.43u. Confocal images are presented as
medial single confocal sections. We performed also a three-dimensional
reconstruction of a Z series of confocal optical sections taken at 0.075 mm
intervals. For colocalization analysis of IFN-g, granzyme A, and granzyme B,
cells with an average signal of these antigens were picked at random. Six to
ten planes with 0.4 mm increment of each cell were taken. The Mander‘s
Immunity
Sortilin Controls Sorting of Effector Moleculesoverlap coefficient for each z stack was calculated with the LSM software ZEN
(Zeiss).
Transferrin Transport Assay
CTLs were incubated with 20 mg/ml Alexa Fluor-488-labeled transferrin
(Invitrogen) in RPMI with 2% FCS at 37C for 30 min. The recycling phase
was induced by washing the cells in ice-cold RPMI, followed by competition
with excessive unlabeled transferrin (Sigma; 103 excess molar ratio) in
RPMI with 10% FCS (4C). Cells were seeded on coverslips, precoated with
3 mg/ml anti-CD3 and 2 mg/ml anti-CD28 for 15 min at 4C, followed by a
chase period at 37C. Cells were fixed with 1%glutaraldehyde, permeabilized,
and stained with the indicated antibodies. For colocalization analysis, cells
with an average signal of Alexa Fluor 488-tagged transferrin were picked at
random.
Laser Scanning Microscopy and Image Analysis
Confocal microscopy images of cells were acquired with a Zeiss LSM510Meta
or LSM700 confocal setup on an Axiovert 200 M inverted microscope equip-
ped with a three-line laser. Microscope settings and image processing are
detailed in Supplemental Experimental Procedures.
Statistics
Results are expressed as mean ± SD or SEM, as indicated. Data were consid-
ered statistically significant for p% 0.05, which was determined by Wilcoxon
signed rank test, Mann-Whitney test, or two-tailed unpaired Student’s t test as
indicated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2012.07.012.
ACKNOWLEDGMENTS
We thank A. Nykjaer for providing Sort1/ mice. We are indebted to M.
Schaefer, C. Brettschneider, A. Bauerfeind, A. Sporbert, H.-P. Rahn, and V.
Schumacher for expert technical advice or assistance. I. Morano generously
provided us with recombinant adenovirus. We are grateful to J. Klumperman
and O. Daumke for helpful discussions.
Received: July 20, 2011
Accepted: July 20, 2012
Published online: October 18, 2012
REFERENCES
Andersson, A., Dai, W.J., Di Santo, J.P., and Brombacher, F. (1998). Early IFN-
gamma production and innate immunity during Listeria monocytogenes infec-
tion in the absence of NK cells. J. Immunol. 161, 5600–5606.
Antonin, W., Holroyd, C., Fasshauer, D., Pabst, S., Von Mollard, G.F., and
Jahn, R. (2000). A SNARE complex mediating fusion of late endosomes
defines conserved properties of SNARE structure and function. EMBO J. 19,
6453–6464.
Beresford, P.J., Xia, Z., Greenberg, A.H., and Lieberman, J. (1999). Granzyme
A loading induces rapid cytolysis and a novel form of DNA damage indepen-
dently of caspase activation. Immunity 10, 585–594.
Canuel, M., Lefrancois, S., Zeng, J., and Morales, C.R. (2008). AP-1 and retro-
mer play opposite roles in the trafficking of sortilin between the Golgi appa-
ratus and the lysosomes. Biochem. Biophys. Res. Commun. 366, 724–730.
Carrero, J.A., Vivanco-Cid, H., and Unanue, E.R. (2008). Granzymes drive
a rapid listeriolysin O-induced T cell apoptosis. J. Immunol. 181, 1365–1374.
Catalfamo, M., Karpova, T., McNally, J., Costes, S.V., Lockett, S.J., Bos, E.,
Peters, P.J., and Henkart, P.A. (2004). Human CD8+ T cells store RANTES in
a unique secretory compartment and release it rapidly after TcR stimulation.
Immunity 20, 219–230.IClark, R.H., Stinchcombe, J.C., Day, A., Blott, E., Booth, S., Bossi, G.,
Hamblin, T., Davies, E.G., and Griffiths, G.M. (2003). Adaptor protein 3-depen-
dent microtubule-mediated movement of lytic granules to the immunological
synapse. Nat. Immunol. 4, 1111–1120.
Dell’Angelica, E.C., Shotelersuk, V., Aguilar, R.C., Gahl, W.A., and Bonifacino,
J.S. (1999). Altered trafficking of lysosomal proteins in Hermansky-Pudlak
syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol.
Cell 3, 11–21.
Ebnet, K., Hausmann, M., Lehmann-Grube, F., Mu¨llbacher, A., Kopf, M.,
Lamers, M., and Simon, M.M. (1995). Granzyme A-deficient mice retain potent
cell-mediated cytotoxicity. EMBO J. 14, 4230–4239.
Evans, S.F., Irmady, K., Ostrow, K., Kim, T., Nykjaer, A., Saftig, P., Blobel, C.,
and Hempstead, B.L. (2011). Neuronal brain-derived neurotrophic factor is
synthesized in excess, with levels regulated by sortilin-mediated trafficking
and lysosomal degradation. J. Biol. Chem. 286, 29556–29567.
Fooksman, D.R., Vardhana, S., Vasiliver-Shamis, G., Liese, J., Blair, D.A.,
Waite, J., Sacrista´n, C., Victora, G.D., Zanin-Zhorov, A., and Dustin, M.L.
(2010). Functional anatomy of T cell activation and synapse formation. Annu.
Rev. Immunol. 28, 79–105.
Fortier, A.H., Nacy, C.A., and Sitkovsky, M.V. (1989). Similar molecular require-
ments for antigen receptor-triggered secretion of interferon and granule
enzymes by cytolytic T lymphocytes. Cell. Immunol. 124, 64–76.
Ghosh, P., Dahms, N.M., and Kornfeld, S. (2003). Mannose 6-phosphate
receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol. 4, 202–212.
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R.,
Vilcek, J., Zinkernagel, R.M., and Aguet, M. (1993). Immune response in mice
that lack the interferon-gamma receptor. Science 259, 1742–1745.
Huse, M., Lillemeier, B.F., Kuhns, M.S., Chen, D.S., and Davis, M.M. (2006). T
cells use two directionally distinct pathways for cytokine secretion. Nat.
Immunol. 7, 247–255.
Ito, H., and Fathman, C.G. (1997). CD45RBhigh CD4+ T cells from IFN-gamma
knockout mice do not induce wasting disease. J. Autoimmun. 10, 455–459.
Kennedy, R., and Celis, E. (2008). Multiple roles for CD4+ T cells in anti-tumor
immune responses. Immunol. Rev. 222, 129–144.
Kojouharoff, G., Hans, W., Obermeier, F., Ma¨nnel, D.N., Andus, T.,
Scho¨lmerich, J., Gross, V., and Falk, W. (1997). Neutralization of tumour
necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran
sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 107, 353–358.
Krzewski, K., Gil-Krzewska, A., Watts, J., Stern, J.N., and Strominger, J.L.
(2011). VAMP4- and VAMP7-expressing vesicles are both required for cyto-
toxic granule exocytosis in NK cells. Eur. J. Immunol. 41, 3323–3329.
Kursar, M., Ho¨pken, U.E., Koch, M., Ko¨hler, A., Lipp, M., Kaufmann, S.H., and
Mittru¨cker, H.W. (2005). Differential requirements for the chemokine receptor
CCR7 in T cell activation during Listeria monocytogenes infection. J. Exp.
Med. 201, 1447–1457.
Marcet-Palacios, M., Odemuyiwa, S.O., Coughlin, J.J., Garofoli, D., Ewen, C.,
Davidson, C.E., Ghaffari, M., Kane, K.P., Lacy, P., Logan, M.R., et al. (2008).
Vesicle-associated membrane protein 7 (VAMP-7) is essential for target cell
killing in a natural killer cell line. Biochem. Biophys. Res. Commun. 366,
617–623.
Mari, M., Bujny, M.V., Zeuschner, D., Geerts, W.J., Griffith, J., Petersen, C.M.,
Cullen, P.J., Klumperman, J., and Geuze, H.J. (2008). SNX1 defines an early
endosomal recycling exit for sortilin and mannose 6-phosphate receptors.
Traffic 9, 380–393.
Poe, M., Wu, J.K., Blake, J.T., Zweerink, H.J., and Sigal, N.H. (1991). The enzy-
matic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis
mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic
antiprotease, FUT-175. Arch. Biochem. Biophys. 284, 215–218.
Pryor, P.R., Mullock, B.M., Bright, N.A., Lindsay, M.R., Gray, S.R., Richardson,
S.C., Stewart, A., James, D.E., Piper, R.C., and Luzio, J.P. (2004).
Combinatorial SNARE complexes with VAMP7 or VAMP8 define different
late endocytic fusion events. EMBO Rep. 5, 590–595.
Reefman, E., Kay, J.G., Wood, S.M., Offenha¨user, C., Brown, D.L., Roy, S.,
Stanley, A.C., Low, P.C., Manderson, A.P., and Stow, J.L. (2010). Cytokinemmunity 37, 854–866, November 16, 2012 ª2012 Elsevier Inc. 865
Immunity
Sortilin Controls Sorting of Effector Moleculessecretion is distinct from secretion of cytotoxic granules in NK cells.
J. Immunol. 184, 4852–4862.
Riedel, D., Antonin, W., Fernandez-Chacon, R., Alvarez de Toledo, G., Jo, T.,
Geppert, M., Valentijn, J.A., Valentijn, K., Jamieson, J.D., Su¨dhof, T.C., and
Jahn, R. (2002). Rab3D is not required for exocrine exocytosis but for mainte-
nance of normally sized secretory granules. Mol. Cell. Biol. 22, 6487–6497.
Robinson, M.S., and Bonifacino, J.S. (2001). Adaptor-related proteins. Curr.
Opin. Cell Biol. 13, 444–453.
Rous, B.A., Reaves, B.J., Ihrke, G., Briggs, J.A., Gray, S.R., Stephens, D.J.,
Banting, G., and Luzio, J.P. (2002). Role of adaptor complex AP-3 in targeting
wild-type and mutated CD63 to lysosomes. Mol. Biol. Cell 13, 1071–1082.
Ru¨der, C., Ho¨pken, U.E., Wolf, J., Mittru¨cker, H.W., Engels, B., Erdmann, B.,
Wollenzin, S., Uckert, W., Do¨rken, B., and Rehm, A. (2009). The tumor-associ-
ated antigen EBAG9 negatively regulates the cytolytic capacity of mouse
CD8+ T cells. J. Clin. Invest. 119, 2184–2203.
Russell, J.H., and Ley, T.J. (2002). Lymphocyte-mediated cytotoxicity. Annu.
Rev. Immunol. 20, 323–370.
Schneider, M.A., Meingassner, J.G., Lipp, M., Moore, H.D., and Rot, A. (2007).
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells.
J. Exp. Med. 204, 735–745.
Stetson, D.B., Mohrs, M., Reinhardt, R.L., Baron, J.L., Wang, Z.E., Gapin, L.,
Kronenberg, M., and Locksley, R.M. (2003). Constitutive cytokine mRNAs
mark natural killer (NK) and NK T cells poised for rapid effector function.
J. Exp. Med. 198, 1069–1076.
Stinchcombe, J., Bossi, G., and Griffiths, G.M. (2004). Linking albinism and
immunity: the secrets of secretory lysosomes. Science 305, 55–59.866 Immunity 37, 854–866, November 16, 2012 ª2012 Elsevier Inc.Sung, R.S., Qin, L., and Bromberg, J.S. (2001). TNFalpha and IFNgamma
induced by innate anti-adenoviral immune responses inhibit adenovirus-medi-
ated transgene expression. Mol. Ther. 3, 757–767.
Trapani, J.A. (2001). Granzymes: a family of lymphocyte granule serine prote-
ases. Genome Biol. 2, REVIEWS3014.
Vaegter, C.B., Jansen, P., Fjorback, A.W., Glerup, S., Skeldal, S., Kjolby, M.,
Richner, M., Erdmann, B., Nyengaard, J.R., Tessarollo, L., et al. (2011).
Sortilin associates with Trk receptors to enhance anterograde transport and
neurotrophin signaling. Nat. Neurosci. 14, 54–61.
Voskoboinik, I., Smyth, M.J., and Trapani, J.A. (2006). Perforin-mediated
target-cell death and immune homeostasis. Nat. Rev. Immunol. 6, 940–952.
Willimsky, G., and Blankenstein, T. (2000). Interleukin-7/B7.1-encoding ade-
noviruses induce rejection of transplanted but not nontransplanted tumors.
Cancer Res. 60, 685–692.
Willnow, T.E., Petersen, C.M., and Nykjaer, A. (2008). VPS10P-domain recep-
tors - regulators of neuronal viability and function. Nat. Rev. Neurosci. 9,
899–909.
Wirtz, S., Finotto, S., Kanzler, S., Lohse, A.W., Blessing, M., Lehr, H.A., Galle,
P.R., and Neurath, M.F. (1999). Cutting edge: chronic intestinal inflammation in
STAT-4 transgenic mice: characterization of disease and adoptive transfer by
TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial anti-
gens. J. Immunol. 162, 1884–1888.
Yang, Y., Ertl, H.C., andWilson, J.M. (1994). MHC class I-restricted cytotoxic T
lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-
deleted recombinant adenoviruses. Immunity 1, 433–442.
